Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HRZN
HRZN logo

HRZN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Horizon Technology Finance Corp (HRZN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
4.210
1 Day change
2.93%
52 Week Range
9.390
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Horizon Technology Finance Corp (HRZN) is not a strong buy at this moment for a beginner investor with a long-term focus. The stock shows mixed signals, with no significant positive catalysts, weak financial performance, and bearish technical indicators. While the company has potential for recovery, the current risk-reward profile does not favor immediate investment.

Technical Analysis

The MACD is positive and expanding, indicating mild bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 4.206, with resistance at 4.355 and support at 4.057. Overall, the technical indicators suggest a cautious stance.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The low Open Interest Put-Call Ratio indicates bullish sentiment, but the high Option Volume Put-Call Ratio suggests bearish short-term trading sentiment.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
4

Positive Catalysts

  • The company has provided a $40 million loan to Hyperfine, which could enhance its market presence and partnerships. Additionally, the upcoming merger with Monroe Capital (MRCC) may reset the portfolio strategy and mix.

Neutral/Negative Catalysts

  • The company reported weak Q4 results with a significant drop in net income (-171.03% YoY) and EPS (-162.50% YoY). Analysts have lowered price targets, and the dividend was cut by 45%. Elevated credit non-accruals remain a concern.

Financial Performance

In Q4 2025, revenue increased significantly by 3106.55% YoY to $22.03M. However, net income dropped by 171.03% YoY to $8.83M, and EPS fell by 162.50% YoY to 0.2. Gross margin also declined sharply by 300.53% YoY to 94.87. The financial performance reflects a mixed picture with growth in revenue but significant profitability challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views on HRZN. Oppenheimer, B. Riley, and Maxim have lowered their price targets, citing weak financial performance and concerns over credit non-accruals. However, Keefe Bruyette upgraded the stock to Market Perform, citing fair valuation and potential benefits from the Monroe Capital merger.

Wall Street analysts forecast HRZN stock price to rise
3 Analyst Rating
Wall Street analysts forecast HRZN stock price to rise
1 Buy
1 Hold
1 Sell
Hold
Current: 4.210
sliders
Low
6
Averages
6.67
High
7.5
Current: 4.210
sliders
Low
6
Averages
6.67
High
7.5
Oppenheimer
Oppenheimer
Perform
downgrade
$7 -> $6
AI Analysis
2026-03-24
Reason
Oppenheimer
Oppenheimer
Price Target
$7 -> $6
AI Analysis
2026-03-24
downgrade
Perform
Reason
Oppenheimer lowered the firm's price target on Horizon Technology to $6 from $7 and keeps a Perform rating on the shares. The firm notes that in Q4, Horizon earned 20c/share as it generated net gains of $0.6M. In FY25 Horizon lost 13c/share as it generated net losses of $47.1M, or $1.18/share, from unrealized losses. Oppenheimer estimates it earns 85c/share and 81c/share in 2026 and 2027, respectively, for ROEs of 12.3% and 11.8%. Estimates reflect updated guidance, it adds.
B. Riley
Neutral
downgrade
$7
2026-03-06
Reason
B. Riley
Price Target
$7
2026-03-06
downgrade
Neutral
Reason
B. Riley lowered the firm's price target on Horizon Technology to $5.50 from $7 and keeps a Neutral rating on the shares. The firm sees the risk/reward largely in line with a discounted .75x P/NAV due to still-elevated credit non-accruals above the group, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HRZN
Unlock Now

People Also Watch